Informatie:
Fout:
ID
34150
Beschrijving
Comparison of Neo-adjuvant Weekly Paclitaxel With or Without Carboplatin in Early Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00919880
Link
https://clinicaltrials.gov/show/NCT00919880
Trefwoorden
Versies (1)
- 14-01-19 14-01-19 -
Houder van rechten
see on clinicaltrials.gov
Geüploaded op
14 januari 2019
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Breast Cancer NCT00919880
Eligibility Breast Cancer NCT00919880
- StudyEvent: Eligibility
Similar models
Eligibility Breast Cancer NCT00919880
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
ID.1
Item
female patients between 18 and 65 years old
boolean
ID.2
Item
pathological diagnosed invasive breast cancer; medium and high risk primary breast cancer according to st. gallen 2007
boolean
ID.3
Item
able and willing to give consent to participate in the study
boolean
ID.4
Item
pregnant or lactating females
boolean
ID.5
Item
previous treatment for breast cancer
boolean
ID.6
Item
other tumor history
boolean
ID.7
Item
instable complication (e.g., myocardial infarction within 6 months, arrhythmia, unstable diabetes, hypercalcemia) or uncontrolled infection
boolean
ID.8
Item
allergy history to similar drugs
boolean
ID.9
Item
concurrent disease or condition that would make the patient inappropriate for study participation
boolean
ID.10
Item
resist to participate in the study
boolean